Delivery Order SPE2DE24D0013-SPE2D625F7NS0

The U.S. Defense Department's Medical Supply Chain awarded a $6,800 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for XPCOV2/FLU/RSV-10 testing solutions. This delivery order, issued on July 18, 2025, with an ultimate completion date of July 25, 2025, carries no set-aside designation and represents procurement of diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The award leverages Cepheid's specialized expertise in developing and supplying advanced molecular diagnostic systems and reagents, which the company has consistently delivered to federal healthcare systems across multiple agencies including the Department of Veterans Affairs and the Defense Health Agency.

This delivery order likely derives from one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, most notably the VA Veterans Integrated Service Network 21 IDV valued at $2.5 million, which specifically covers PCR testing for laboratory microbiology including COVID-19, influenza, and RSV diagnostics. Cepheid's established track record with the Defense Department and Veterans Affairs, combined with its GeneXpert diagnostic platform and associated molecular reagents, positions the company as a key supplier for federal point-of-care and laboratory diagnostic needs. The relatively short performance timeline and modest ceiling value suggest this delivery order fulfills immediate diagnostic testing requirements through Cepheid's existing contract infrastructure.